At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
Deep brain stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Deep Brain Stimulation of the Posterior Subthalamic Area (PSA) Versus Subthalamic Nucleus (STN) for Tremor-dominant Parkinson's Disease: a Prospective, Randomized, Double-blinded, Cross-over Trial
In Brief
A clinical study evaluating Deep brain stimulation for Parkinson Disease. Completed, enrolled 27 participants across 1 site.
Detailed Summary
The aim of this study is to compare the effectiveness of the deep brain stimulation in the posterior subthalamic area (PSA) versus the subthalamic nucleus (STN) for the treatment of tremor-dominant Parkinson's disease (PD) in a randomized, double-blinded, cross-over manner.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesChina
CollaboratorsSuzhou Sceneray Medical Co. , Ltd
Timeline
N/ACompletedFinished
2023202420252026
First PostedMay 2022
Enrollment StartJun 2022
Primary CompletionApr 2025
Study CompletionAug 2025
TodayJul 2026
First PostedMay 19, 2022
Enrollment StartJun 1, 2022
Primary CompletionApr 24, 2025
Study CompletionAug 26, 2025
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 4.1 years ago
Interventions
Deep brain stimulationdevice
active DBS with optimal stimulating parameters